Establishment of brain bank and blood/cerebrospinal fluid-based reference laboratory for diagnosis of dementia
Not Applicable
Recruiting
- Conditions
- Diseases of the nervous system
- Registration Number
- KCT0003489
- Lead Sponsor
- Pusan National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Neurodegenerative diseases: Alzheimer's disease, frontotemporal dementia, dementia with lewy bodies, parkinson's disease, multisystematrophy, progressive supranuclear palsy syndrome, corticobasal degeneration syndrome, other neurological and neuropsychiatric diseases, cognitively healthy adults
Exclusion Criteria
no exclusion criteria
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pathological diagnosis
- Secondary Outcome Measures
Name Time Method clinical diagnosis, demographics, clinical data
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular biomarkers are being studied in KCT0003489 for Alzheimer's disease diagnosis?
How does the KCT0003489 brain bank contribute to understanding Alzheimer's pathophysiology?
What are the comparative diagnostic accuracies of CSF and blood biomarkers in Alzheimer's research?
What adverse events are associated with current Alzheimer's fluid biomarker testing methods?
How do amyloid-beta and tau biomarkers in KCT0003489 relate to other dementia subtypes like vascular or Lewy body dementia?